Author

Giulia Lestini

Observed name: G Lestini

Institution: Novartis (Switzerland)

Observed institutions: Novartis (Switzerland), Inserm, University of Pavia, Sorbonne Paris Cité, Université Paris Diderot, Infection, Anti-microbiens, Modélisation, Evolution

ORCID: 0009-0003-8904-7429

Observed ORCID: 0009-0003-8904-7429

OpenAlex ID: A5083000448

First‐in‐human safety, tolerability, and pharmacokinetic results of DFV890, an oral low‐molecular‐weight NLRP3 inhibitor

2024 · Ewa Gatlik, Beata Mehes, et al. · Clinical and Translational Science · 69

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

2015 · MJ Swat, S Moodie, et al. · CPT Pharmacometrics & Systems Pharmacology · 39

PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models

2018 · Cyrielle Dumont, Giulia Lestini, et al. · Computer Methods and Programs in Biomedicine · 38

Model Description Language (MDL): A Standard for Modeling and Simulation

2017 · Mike K. Smith, Stuart L. Moodie, et al. · CPT Pharmacometrics & Systems Pharmacology · 17

Influence of the Size of Cohorts in Adaptive Design for Nonlinear Mixed Effects Models: An Evaluation by Simulation for a Pharmacokinetic and Pharmacodynamic Model for a Biomarker in Oncology

2015 · Giulia Lestini, Cyrielle Dumont, et al. · Pharmaceutical Research · 16

Optimal Design for Informative Protocols in Xenograft Tumor Growth Inhibition Experiments in Mice

2016 · Giulia Lestini, France Mentré, et al. · The AAPS Journal · 13

Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function

2026 · Cha Lin, Hao Wu, et al. · EBioMedicine · 6

#4447 Effect of Renal Impairment on Iptacopan Pharmacokinetics

2023 · Robert Schmouder, Giulia Lestini, et al. · Nephrology Dialysis Transplantation · 3

Brain MRI signatures across sex and CSF Alzheimer’s disease biomarkers

2025 · You Cheng, Yingnan He, et al. · Brain Communications · 1

Concentration response analyses for QT data with several active compounds

2026 · Günter Heimann, Giulia Lestini, et al. · Journal of Pharmacokinetics and Pharmacodynamics

Prm24 - a Joint Model of Cognitive Decline and Time to Diagnosis to Improve Predictions of the Risk of Developing Alzheimer’s Disease

2018 · H Karcher, V Risson, et al. · Value in Health

Works count: 11

Citation count: 202

H-index: 6

I10-index: 6